Get Your FREE Picks for May 18 2024  Click here

MiMedx, MDXG, Company Profile, Stock Summary

MiMedx, MDXG, Company Profile, Stock Summary

MiMedx® is a biopharmaceutical company developing, manufacturing and marketing regenerative biologics utilizing human placental allografts for multiple sectors of healthcare. “Innovations in Regenerative Medicine” is the framework behind our mission to provide physicians with products and tissues to help the body heal itself.

The company has developed a proprietary human placental tissue processing method called PURION®. MiMedx produces safe and effective allografts by employing aseptic processing techniques in addition to terminal sterilization.

Since its founding, research and development has been the cornerstone of this organization. The company is a leader in placental based products with over 40 scientific and clinical publications, multiple published Randomized Controlled Trials (RCTs), and 30 ongoing clinical studies.

MiMedx has over 45 placental tissue issued and allowed patents and over 90 pending applications. MiMedx has supplied over 1.3 million placental tissue-based allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

PURION® Process

Human amniotic membrane allografts have been used for a variety of reconstructive surgical procedures since the early 1900s. The use of the amniotic membrane as an allograft has accelerated due to the development of the PURION® process, which among other things allows the tissue to be dehydrated and sterilized. 

 

The proprietary PURION process safely and gently separates placental tissues, cleans and reassembles layers, and then dehydrates the tissue to preserve the key elements associated with healing. The PURION process removes blood components while protecting the delicate scaffold of the amniotic membrane, leaving an intact extracellular matrix. The result is a durable graft with natural barrier properties that offers clinicians a clear advantage in soft tissue applications. PURION processed dehydrated human amnion/chorion allografts can be stored at ambient conditions for up to five years.

The proprietary process has been specifically designed to deliver a clinically effective and minimally manipulated allograft tissue. All placental tissues are recovered under sterile conditions from patients who have been screened for underlying infectious disease. No chemicals are used in the PURION Process that might result in chemical cross-linking or decellularization.

 

Amniotic Membrane Description

Human amniotic membrane is comprised of the innermost layer of the placenta and lines the amniotic cavity. The membrane is composed of multiple layers including a single layer of epithelial cells, a basement membrane and an avascular connective tissue matrix. The tissues of the placenta present a very complex interrelationship of materials that possess numerous physiologic characteristics that can in turn change in importance with the appropriate stage of gestation.  During pregnancy, the placenta permits the passage of nutrients, metabolites and metabolic gases, and provides physical and immunological protection to the developing fetus.  In addition, it produces a variety of steroids and important metabolic hormones.8

Amniotic membrane is a unique material and its composition contains collagen types I, III, IV, V, and VII.  Amniotic membrane is composed of structural extracellular matrix (ECM), that also contains specialized proteins fibronectin, laminins, proteoglycans and glycosaminoglycans. In addition, amniotic membrane contains essential, active, healing growth factors such as epidermal growth factor (EGF), transforming growth factor beta (TGF-b), fibroblast growth factor (FGF), and platelet derived growth factor (PDGF).8 Amniotic tissues have shown little to no HLA-A, B, C antigens and β2 microglobulin.3

 

Source: The Company, OxBridge Research, Daily Stock Deals, OTC Stock Wire

 

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks. 

If you want to get your company featured on Daily Stock Deal or want to learn more, please contact the Editor. Thanks you!

Increase investor interaction and engagement effortlessly!

Connect with investors at scale!

Actionable Tools!
Free proprietary techniques and onboarding tools to help you acquire and retain more investors!
Deep links and other integration tools to drive more investors to your own website!

 

Achieve staggering results with proven trust building tools!

Investors are hungry for information they can trust, and we have earned their trust by providing actionable information for more than 10 years!


Smart CEOs know Daily Stock Deal can deliver better outcome more efficiently and at a lower cost.

Daily Stock Deals has liberated CEOs from the daily IR minutia!

Our clients spend more time signing New Deals and orchestrating New Mergers

Stop Wasting your time on IR!

Start Building Your Company, and that's what investors want from you!

If you want to get rewarded, Don't try to be an IR Champion! 

Leave Investor Communication to Daily Stock Deals!

We've got the tools!

Copyright©2017 Daily Stock Deals TM,

Today's Top 10 Stocks TM, All Rights Reserved Worldwide.

Daily Stock Deals is a division of Placebo Media Group

Get in Touch

Daily Stock Deals

A Sound View Plaza 1266 E Main St. 7th Floor, Stamford, CT 06902 USA

T 214 810 5549

Comodo SSL